Clinical Trial 44013

Raleigh, NC 27607


Summary:

Moderate to severe asthma can control your entire life. The risk of an attack and the anxiety that goes with it, is always on your mind. Wouldn’t it be nice to finally breathe easy?


Right now, a new clinical research study that will be evaluating an oral investigational medication for moderate to severe
asthma is seeking participants. Studies like these are the first step towards finding more effective treatments for conditions like moderate to severe asthma. Take a more active role in your healthcare and consider enrolling today.
 


You may qualify if you:


- Are between the ages of 18 and 75


- Have a diagnosis of moderate to severe asthma for
at least 12 months


- Are using a dual corticosteroid/long-acting beta-agonist
(ICS/LABA) inhaler, such as Advair®, Symbicort®, Dulera®,
AirDuo®, Wixela®, or Breo®.
 


Qualified Participants May Receive:

-Study-related care will be provided at no cost and will not be
billed. Health insurance is not needed.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.